Author Topic: Marijuana use sinful for Catholics? (Read 52922 times)

Viva Cristo Rey · « **Reply #435 on:** March 29, 2022, 05:19:46 PM »

Are you growing it yourself or are you buying from a drug dealer who sells to children or sex traffic young girls??

Viva Cristo Rey · « **Reply #436 on:** March 29, 2022, 05:28:13 PM »

Most of you who smoke pot are probably in your 50s?

What is your diet? Junkfood or do you eat healthy? Just curious.

Mark 79 · « **Reply #437 on:** March 29, 2022, 05:54:29 PM »

Quote from: Viva Cristo Rey on March 29, 2022, 05:19:46 PM

Are you growing it yourself or are you buying from a drug dealer who sells to children or sex traffic young girls??

Have you stopped abusing your children?

Mark 79 · « **Reply #438 on:** March 29, 2022, 05:54:57 PM »

Quote from: Mark 79 on March 29, 2022, 03:15:17 PM

The endocannabinoid system—whazzat?

Your body makes, uses, and needs marijuana-like chemicals called “endocannabinoids.” Your physical and mental health require these endocannabinoids. Members of the Animal Kingdom, from sponges to men, have nerve and other organ receptors that respond to endocannabinoids. A basic understanding of the nervous system illustrates how these endocannabinoids work.

The basics

The nervous system works using the movement of chemicals and electricity. In its most simplified fashion, electrochemical activity usually proceeds along the “wires” (axons) of nerve cells (“neurons”) to the tip where special chemicals (“neurotransmitters”) are released into a space between neighboring neurons. The space is called a “synapse”. The neurotransmitter is released from a “presynaptic” neuron, and then diffuses across the synapse to bind to receptors in the neighboring “postsynaptic” neuron.

Neurotransmitters fit specific receptors to activate (or block) those receptors, sort of like a key in a lock. Our own bodies make endocannabinoids that fit our endocannabinoid receptors. Marijuana works because many of marijuana’s chemicals are like “keys” that fit and activate our different endocannabinoid “locks.” Marijuana’s chemicals are “phytocannabinoids,” plant cannabinoids.

Endocannabinoids are unique in a few respects. Most neurotransmitters are synthesized in advance by the presynaptic neurons to be stored in tiny packets (“vesicles”) in the cells to be available when needed. Endocannabinoids are not synthesized in advance and stored, but are synthesized on demand for immediate release. Also, it is not the presynaptic neurons but the postsynaptic neurons that synthesize the endocannabinoids. This means that the endocannabinoids are released into the synapse and then diffuse backwards to affect the presynaptic neuron. In a sense, the chemicals go against the flow of “electricity” to modulate the flow of “electricity,” hence endocannabinoids are sometimes classed as “neuromodulators.” Similar chemical interactions also occur in the organs outside of the nervous system.
The chemicals

Endocannabinoids are fats (“lipids”), so are able to diffuse quickly through lipid-laden tissues and membranes. In 1992 Anandamide, also known as N-arachidonylethanolamine or “AEA”, was the first endocannabinoid identified and was named from the Sanskrit word “ananda” (“bliss”) joined with “amide,” the name of its general chemical class. So far, other identified endocannabinoids include 2-arachidonylyglycerol (“2-AG”), 2-arachidonyl glyceryl ether (noladin ether), O-arachidonyl ethanolamine (“OAE” or virodhamine), and N-arachidonyl dopamine (NADA). While “your” government tells you there is no medical use for marijuana, Big Pharma has been developing proprietary variations of endocannabinoids and marijuana’s chemicals to sell you.

The receptor subtypes

In man the endocannabinoids bind to endocannabinoid receptors of different subtypes distributed throughout our many organ systems. The best characterized of these receptor subtypes are the CB1 and CB2 receptors, however there are likely at least three additional subtypes that are temporarily and not very cleverly named “non-CB1/non-CB2” receptors.

CB1 receptors

CB1 receptors are most widely found in the brain, but are not found in the brainstem, the medulla, where our important respiratory and heart control centers are located. It is thought that the absence of cannabinoids receptors in the brainstem accounts for the enormous safety of marijuana. Cannabinoids, unlike opiates, cannot depress the brainstem’s control centers of respiratory and heart function. CB1 receptors are not limited to the brain, but are also widely distributed in the pituitary, thyroid, adrenals, liver, lung, kidney, gut, pain receptors, and even our reproductive systems. Endocannabinoids are suspected to play a role in regulating the implantation of newly conceived babies. There appears to be an optimum level of endocannabinoids for fertility. If levels are too high or too low the baby will not implant properly or grow in the mother’s womb.

A strain of laboratory mice without CB1 receptors, known as “CB1 knockout mice,” suffer from severe memory problems and die early from stroke and heart attack. These observations in mice correlate with research in humans showing the importance of cannabinoids in modulating memory, cardiovascular function, and nerve-protecting effects.

It is well known that cannabis affects appetite, gives you “the munchies,” and also makes you happy. Research aimed at the role of cannabis in appetite led to the development of very potent appetite suppressants. A drug that blocks CB1 receptors, Rimonabant, was a very effective and widely prescribed appetite suppressant in Europe. Despite its effectiveness in dieting, Rimonabant was pulled from the market. Why? Big Pharma’s drug so completely blocked patients’ natural endocannabinoids that patients were deprived of not only their craving for food, but also deprived of their mental health. Because Rimonabant blocked the mood stabilizing effects of natural endocannabinoids, Rimonabant users were committing ѕυιcιdє in significant numbers.

What do we learn from these observations? Endocannabinoids maintain our physical health and mental stability. Yes, Divine Providence at work—happy minds and healthy bodies require marijuana-like chemicals!

CB2 receptors

CB2 receptors are also widely distributed, most notably throughout the immune system (T-cells, B-cells, macrophages, monocytes, etc.) and hematopoietic (blood-making) system of the spleen, liver, tonsils, thymus, and bone marrow. CB2 receptors are found in the brain, but unlike CB1 receptors that are mostly observed on neurons, the nerve cells, CB2 receptors are found primarily on microglia, the support and immune cells of the brain and spinal cord. CB2 receptors are also prevalent in the gastrointestinal tract and bone. Stimulation of CB2 receptors by endocannabinoids and by marijuana’s phytocannabinoids, especially cannabidiol (“CBD”), appears to down-regulate both the immune system and pain receptors. Endocannabinoids also help to maintain bone mass, preventing osteoporosis.

It is likely that such down-regulated CB2 receptor activity in pain receptors, the immune system, and the gut explains the observed effectiveness of marijuana in reducing inflammation and pain, especially in inflammatory bowel diseases like Crohn’s Disease and ulcerative colitis, and in neuropathic pain, pain due to disorders of pain receptors. Effects on microglial cells may explain not just the palliative (symptom reduction) effects of marijuana, but also the curative effects observed by some researchers in Alzheimer’s Disease, multiple sclerosis, and a particularly aggressive type of brain cancer, glioblastoma multiforme. Researchers have observed that cannabinoids reduce the hallmark amyloid deposition and neurofibrillatory tangles of Alzheimer’s Disease, the demyelination of multiple sclerosis, and numerous types of cancers.

Future developments

As the term “non-CB1/non-CB2 receptors” implies, there are a variety of other receptors that remain to be characterized and their roles elucidated. And so there are…

Mark 79 · « **Reply #439 on:** March 29, 2022, 05:55:52 PM »

Quote from: Mark 79 on March 29, 2022, 05:50:33 PM

Phytocanabinoids•THC and other marijuana chemicals

Our bodies make a variety of marijuana-like chemicals called “endocannabinoids” that activate many brain, pain receptor, and other endocannabinoid receptors distributed throughout the tissues and organs of our bodies. As you would expect, the activation of these endocannabinoid receptors affects and regulates the chemical processes of our bodies—pain, inflammation, immune response, cardiovascular function, gastrointestinal function, etc.

How necessary to our health are these cannabinoid systems? Recall the European diet drug Rimonabant™. Rimonabant blocked endocannabinoid receptors and was a fabulously effective diet drug. Unfortunately, Rimonabant so effectively blocked cannabinoid receptors that it caused such severe depression that patients taking Rimonabant committed ѕυιcιdє and the drug had to be pulled from the market. Activation of cannabinoid receptors is essential to mental health and life itself.

THC and the other unique chemicals of the marijuana plant, cannabis, are categorized as “phytocannabinoids,” namely, “plant cannabinoids.” THC and other phytocannabinoids mimic our own endocannabinoids because, in three dimensions, the phytocannabinoids are shaped like our endocannabinoids. Because of their similar shape, phytocannabinoids activate our endocannabinoid receptors. It is no surprise then that marijuana’s chemicals cause a multiplicity of pleasant and beneficial effects, enhancing physical and mental health. Recall too that, quite unlike the medical and recreational drugs marijuana replaces, marijuana has never caused a fatality. In a 1997 New England Journal of Medicine article “Reefer Madness–The Federal Response to California's Medical-Marijuana Law” (N Engl J Med. 1997 Aug 7; 337(6): 435-9.), George Annas calculated that one would have to smoke “nearly 1500 pounds of marijuana within about fifteen minutes to induce a lethal response,” a death by asphyxiation, not drug toxicity. Unless a 1-ton bale of marijuana falls on your head, marijuana cannot kill you. You cannot say the same for aspirin, oxycodone, or even alcohol.

In 1964 THC was the first of marijuana’s unique chemicals to be isolated, but discovery of CBD and numerous other cannabinoids quickly followed. Marijuana has other unique cannabinoids, “terpenophenolic” chemicals that, besides giving marijuana strains their unique scent and flavor properties, are being discovered to have medical benefits. Let’s focus on the two most-studied cannabinoids, THC and CBD.

THC

THC, short for ∆9-tetrahydrocannabinol, read “delta-9-tetrahydrocannabinol,” is marketed commercially as “dronabinol” or Marinol™ and is the most psychoactive of marijuana’s chemicals. THC partially activates CB1 and CB2 receptors about equally (see https://www.cathinfo.com/health-and-nutrition/the-endocannabinoid-systemwhazzat/). THC mimics the endocannabinoid anandamide and so eases pain and is thought to account for the neuroprotective effects of marijuana (e.g., the decreases in the damaging demyelination of multiple sclerosis, amyloid deposition and neurofibrillatory tangles of Alzheimer’s Disease, and even regression of the aggressive “GBM” brain cancer, glioblastoma multiforme).

THC and other cannabinoids dissolve poorly in water, but dissolve well in fats, glycerine, and alcohol. Their relative insolubility in water explains why the cannabinoids resin-making cells of marijuana, the “trichomes,” can be separated by cold-water extraction methods to make bubble hash without the trichomes’ active ingredients simply dissolving into a soupy tea in your hash bags. Because some of the characteristic chemicals of marijuana do dissolve in water, some compounds are washed away by the cold-water method and so connoisseurs do note a blandness of bubble hash in comparison with hash made by traditional methods. On the other hand, the non-traditional methods of extraction do provide the “full melt” characteristic that lends so well to vaporization. Qualified patients who wish to study these methods in depth should consult the 2010 second edition of Robert Connell Clarke’s book Hashish.

Too, THC’s excellent solubility in fats, glycerine, and alcohol explains why butter, oils, glycerine, and liquor make such effective extracts and tinctures.

CBD

CBD, short for “cannabidiol,” acts by influencing endocannabinoids, phytocannabinoids, and serotonin. While there is evidence that CBD directly activates CB1 or CB2 receptors, CBD’s indirect actions chemically competing with THC and other cannabinoids may also be important. CBD has also been shown to activate a certain subset of serotonin receptors, the 5-HT1A receptors (receptors related to commonly prescribed anti-depressants such as Prozac and Zoloft).

It is often, but inaccurately, said that CBD is not psychoactive. CBD does moderate the cerebral “high” of THC. Strains of marijuana high in CBD are less psychoactive than the percentage of THC would otherwise suggest, but CBD does display its own subtle psychoactivity. Paradoxically, some CBD research has shown that CBD can be sedating while other research shows CBD increases alertness. Interest in CBD, however, does not center on its subtle psychoactive properties. Instead CBD is receiving increasing attention for its remarkable anti-epilepsy, anti-inflammatory, anti-anxiety, anti-nausea, and even anti-cancer benefits. CBD inhibits cancer cell growth through a combination of actions (CB2 receptor, TrpV1 capsaicin-receptor, down-regulation of the ID1 oncogene, and induction of oxidative stress) that force “apoptosis,” forcing the programmed cell death from which cancers escape.

To reap these benefits of CBD, breeders have developed high-CBD strains of marijuana. Currently the Society of Cannabis Clinicians defines high-CBD strains as those with greater than 4% CBD by weight or greater than 2.5% CBD if CBD exceeds THC content. Typical medical grade cannabis may have only 0.5-1% CBD, but 14-18% THC. Among the better known high-CBD strains (percentages vary greatly depending on drying, curing and storage, but are reported here as tested by Steep Hill Lab, Oakland CA): Cannatonic 6% CBD/6% THC (Resin Seeds, Barcelona, Spain), Harlequin 8-9% CBD/5.5-6% THC (Cornerstone Research Collective, Los Angeles CA), Women’s Collective Stinky Purple 9.7% CBD/1.2% THC, and the champion, outdoor-grown “True Blueberry x OG Kush” 13.9% CBD/6-7% THC (Full Spectrum Genetics, Yreka CA).

Patient preferences and needs vary. Some prefer and need more THC; others prefer and need more CBD. Besides choice of strains, patients have another method to adjust their relative THC and CBD dosages, vaporizing their medicine. Vaporizing or “vaping” involves heating the medicine to a temperature below the combustion temperature, the temperature at which the marijuana actually burns, approximately 200°C. (392°F.). This allows the inhalation of the vaporized medicine without inhaling actual smoke.

THC and CBD vaporize (turn from a solid into a gas) at different temperatures. THC vaporizes at 157°C. (315°F.) and CBD at 188°C. (370°F.). By adjusting the temperature of a quality vaporizer like the Storz and Bickel Volcano® (http://www.storz-bickel.com), patients may selectively inhale medicine that is THC-rich or CBD-rich.

To obtain THC-rich medicine, simply set the vaporizer for 160°C. and titrate your inhalation of the collected vapor.

To obtain CBD-rich medicine, set the vaporizer for 160°C., allow all the THC to be vaporized without collecting it (or collect it to be used by another patient that prefers the THC-rich fraction). After all the THC has vaporized, turn up the vaporizer temperature to 190°C. and titrate your inhalation of the now CBD-enriched vapor.

For the history and to follow promising developments in the study of CBD, I refer readers to http://www.projectCBD.com.

“Et cetera, et cetera, et cetera”

This is, of course, a short and simplified overview. Approximately 100 phytocannabinoids have been isolated from marijuana, so stay tuned. Much more remains to be known about other common cannabinoids: CBG (Cannabigerol), CBC (Cannabichromene), CBL (Cannabicyclol), CBV (Cannabivarin), THCV (Tetrahydrocannabivarin), CBDV (Cannabidivarin), CBCV (Cannabichromevarin), CBGV (Cannabigerovarin), and CBGM (Cannabigerol Monoethyl Ether).

pharmacologic effects of phytocannabinoids

In 2003 the US government awarded itself US patent #6630507 for cannabinoids as antioxidants and neuroprotectants. No, you are not confused; that is the same federal government that classifies marijuana as a Schedule 1 drug because it supposedly has no medical usefulness. Go figure.

Underscoring “our” government’s hypocrisy regarding inexpensive and easily-grown marijuana is the recognition that besides endocannabinoids and phytocannabinoids, there is a third class of cannabinoids, synthetic cannabinoids, the drugs that Big Pharma is patenting to sell you. Wanna bet whether the feds will classify those expensive synthetic drugs as Schedule 1 having “no medical benefit”? Follow the money.

It is worth mentioning that marijuana is not the only plant with phytocannabinoids.

Mark 79 · « **Reply #440 on:** March 29, 2022, 05:56:19 PM »

Quote from: Mark 79 on December 31, 2021, 04:55:40 PM

Important reviews
University of California Center for Medical Cannabis Research—2010 Report to the Legislature
http://www.cmcr.ucsd.edu/images/pdfs/CMCR_REPORT_FEB17.pdf
Review on clinical studies with cannabis and cannabinoids 2005-2009. Hazecamp A and Grotenhermen F. Cannabinoids 2010;5(special issue):1-21.
www.cannabis-med.org/data/pdf/en_2010_01_special.pdf
Cannabinoids in medicine: A review of their therapeutic potential. Amar MB. Journal of Ethnopharmacology 105 (2006) 1–25.
http://www.ucla.edu.ve/dmedicin/departamentos/fisiologia/cannabinoidsRevPatologias.pdf
Emerging Clinical Applications for Cannabis and Cannabinoids: A Review of the Recent Scientific Literature, 2000 – 2010. Armentano P. NORML Foundation, Washington DC 2010.
http://norml.org/pdf_files/NORML_Clinical_Applications_for_Cannabis_and_Cannabinoids.pdf
Marijuana and Medicine: Assessing the Science Base. National Academy of Science Institute of Medicine, 1999
http://www.nap.edu/openbook.php?record_id=6376
popularized in: Marijuana As Medicine? – The Science Behind the Controversy. Mack A and Joy J. National Academy of Science. National Academy Press, Washington DC 2000.
http://books.nap.edu/openbook.php?record_id=9586&page=R1
AIDS/HIV
University of California Center for Medical Cannabis Research—2010 Report to the Legislature
http://www.cmcr.ucsd.edu/images/pdfs/CMCR_REPORT_FEB17.pdf
Human Immunodeficiency Virus (HIV)
http://www.norml.org/index.cfm?Group_ID=7485
“Marijuana and AIDS” in Marijuana As Medicine? – The Science Behind the Controversy. Mack A and Joy J. National Academy of Science. National Academy Press, Washington DC 2000.
http://books.nap.edu/openbook.php?record_id=9586&page=86
ALS (Amyotrophic Lateral Sclerosis, Lou Gehrig's Disease)
Amyotrophic Lateral Sclerosis (ALS)
http://www.norml.org/index.cfm?Group_ID=7004
Alzheimer's Disease
Alzheimer's Disease
http://norml.org/index.cfm?Group_ID=7003
Cachexia. Wasting syndrome
See sections 3.1 and 3.2 of Cannabinoids in medicine: A review of their therapeutic potential. Amar MB. Journal of Ethnopharmacology 105 (2006) 1–25.
http://www.ucla.edu.ve/dmedicin/departamentos/fisiologia/cannabinoidsRevPatologias.pdf
Cancer
Gliomas/Cancer
http://www.norml.org/index.cfm?Group_ID=7008
“Marijuana and Cancer” in Marijuana As Medicine? – The Science Behind the Controversy. Mack A and Joy J. National Academy of Science. National Academy Press, Washington DC 2000.
http://books.nap.edu/openbook.php?record_id=9586&page=95
Cannabis and Cannabinoids (PDQ®). National Cancer Institute. 2011.
http://www.cancer.gov/cancertopics/pdq/cam/cannabis/healthprofessional/page1
Cardiovascular disease
The Potential for Clinical Use of Cannabinoids in Treatment
of Cardiovascular Diseases. Durst R and Lotan C. Cardiovascular Therapeutics 2011 Feb;29(1):17-22. doi: 10.1111/j.1755-5922.2010.00233.x. Epub 2010 Oct 14.
http://www.ncbi.nlm.nih.gov/pubmed/20946323
The emerging role of the endocannabinoid system in cardiovascular disease. Pacher P, Steffens S. Semin Immunopathol. 2009 Jun;31(1):63-77. Epub 2009 Apr 9.
http://www.springerlink.com/content/a04103g160h16450/fulltext.pdf
Cannabinoid receptors in atherosclerosis. Steffens S, Mach F. Curr Opin Lipidol. 2006 Oct;17(5):519-26.
http://journals.lww.com/co-lipidology/Abstract/2006/10000/Cannabinoid_receptors_in_atherosclerosis.5.aspx
Cannabinoid receptors in acute and chronic complications of atherosclerosis. Mach F, Montecucco F, Steffens S. Br J Pharmacol. 2008 January; 153(2): 290–298.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219535/pdf/0707517a.pdf
Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning. Pacher P, Haskó G. Br J Pharmacol. 2008 Jan;153(2):252-62. Epub 2007 Nov 19.
http://onlinelibrary.wiley.com/doi/10.1038/sj.bjp.0707582/pdf
The role of the endocannabinoid system in atherosclerosis. Mach F, Steffens S. J Neuroendocrinol. 2008 May;20 Suppl 1:53-7.
http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2826.2008.01685.x/pdf
Cardiovascular Effects of Cannabis | Medicinal Cannabis Information. Independent Drug Monitoring Unit, United Kingdom, undated
http://www.idmu.co.uk/canncardio.htm
Crohns Disease
Gastrointestinal Disorders
http://www.norml.org/index.cfm?Group_ID=7009
Endocannabinoid sysytem
The Endocannabinoid System as an Emerging Target of Pharmacotherapy. National Institute of Health: Pacher P, Bátkai S, Kunos G. Pharmacol Rev. 2006 Sep;58(3):389-462.
http://pharmrev.aspetjournals.org/content/58/3/389.full.pdf
Endocrine disease, diabetes
The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Pagotto U, Marsicano G, Cota D, Lutz B, Pasquali R. Endocr Rev. 2006 Feb;27(1):73-100. Epub 2005 Nov 23.
http://fk.uwks.ac.id/elib/Arsip/Departemen/Biokimia/The%20Emerging%20Role%20of%20the%20Endocannabinoid%20System.pdf
Fibromyalgia
Nabilone for the Treatment of Pain in Fibromyalgia. Skrabek RQ, Galimova L, Ethans K, Perry D. J Pain. 2008 Feb;9(2):164-73. Epub 2007 Nov 5.
http://docs.google.com/viewer?a=v&q=cache:9gDyCVhqJSMJ:files.meetup.com/404848/2008_Nabilone-for-the-Treatment-of-Pain-in-Fibromyalgia.pdf+Nabilone+for+the+Treatment+of+Pain+in+Fibromyalgia&hl=en&gl=us&pid=bl&srcid=ADGEESjFGavzxEJkBjsOj_YyWPHuo5PRG034PLna8X6n3sXGT696PVuaEH15HF07xVpfV10wLPfon8-nZoD0RcJfU6LInnuqHOGpKDECN4oQ6OWBgGgwXWckH2QB31FTn1BZn0KX9U7A&sig=AHIEtbQlDN8uMzxJIm6KKL0POTJdhmbsvg
Delta-9-THC based monotherapy in fibromyalgia patients on experimentally induced pain, axon reflex flare, and pain relief. Schley M, Legler A, Skopp G, Schmelz M, Konrad C, Rukwied R. Curr Med Res Opin. 2006 Jul;22(7):1269-76.
http://www.ncbi.nlm.nih.gov/pubmed/16834825
Fibromyalgia
http://norml.org/index.cfm?Group_ID=7007
Glaucoma
American Glaucoma Society position statement: Marijuana and the treatment of glaucoma. American Glaucoma Society, Prepared by Henry Jampel, M.D., M.H.S., August 10, 2009
http://www.americanglaucomasociety.net/associations/5224/files/Marijuana%20and%20Glaucoma%20august%2030_BOD%20Approved%2010.23.09.pdf
Marijuana and Glaucoma” in Marijuana As Medicine? – The Science Behind the Controversy. Mack A and Joy J. National Academy of Science. National Academy Press, Washington DC 2000.
http://books.nap.edu/openbook.php?record_id=9586&page=124
Hepatitis C
Hepatitis C
http://www.norml.org/index.cfm?Group_ID=7010
Marijuana effects, drug levels, DUI
Marijuana effect and delta9-tetrahydrocannabinol plasma level. Chiang CWN and Barnett G. Clinical Pharmacology and Therapeutics 1984 Aug;36(2):234-8.
http://www.ncbi.nlm.nih.gov/pubmed/6086207
Contact highs and urinary cannabinoids excretion after passive exposure to marijuana smoke. Cone EJ and Johnson RE. Clinical Pharmacology and Therapeutics 1986 Sep;40(3):247-56.
http://www.ncbi.nlm.nih.gov/pubmed/3017628
Do delta9-tetrahydrocannabinol concentrations indicate recent use in chronic cannabis users? Karschner EL, Schwilke EW, Lowe RH, Darwin WD, Pope HG, Herning R, Cadet JL, Huestis MA. Addiction. 2009 Dec;104(12):2041-8. Epub 2009 Oct 5.
http://www.clinchem.org/cgi/reprint/49/7/1114
Developing limits for driving under cannabis. Grotenhermen F, Leson G, Berghaus G, Drummer OH, Krüger HP, Longo M, Moskowitz H, Perrine B, Ramaekers JG, Smiley A, Tunbridge R. Addiction 2007 Dec;102(12):1910-7. Epub 2007 Oct 4.
http://www.ncbi.nlm.nih.gov/pubmed/17916224
Urinary cannabinoid detection times after controlled oral administration of delta9-tetrahydrocannabinol to humans. Gustafson RA, Levine B, Stout PR, Klette KL, George MP, Moolchan ET, Huestis MA. Clin Chem. 2003 Jul;49(7):1114-24.
http://www.ncbi.nlm.nih.gov/pubmed/12816908
Editorial: Practical Challenges to Positive Drug Tests for Marijuana. ElSohly MA. Clin Chem. 2003 Jul;49(7):1037-8.
http://www.clinchem.org/cgi/reprint/49/7/1037
Dose related risk of motor vehicle crashes after cannabis use. Ramaekers JG, Berghaus G, van Laar M, Drummer OH. Drug Alcohol Depend. 2004 Feb 7;73(2):109-19.
http://www.ukcia.org/research/DoseRelatedRiskOfCrashes.pdf
Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users. Ramaekers JG, Theunissen EL, de Brouwer M, Toennes SW, Moeller MR, Kauert G. Psychopharmacology (Berl). 2011 Mar;214(2):391-401. Epub 2010 Oct 30.
http://www.cannabistherapyinstitute.com/bills/dui/raemakers.etal.pdf
Cannabis and Driving: A Scientific and Rational Review. Armentano P. NORML Foundation, Washington DC 2010
http://norml.org/index.cfm?Group_ID=7459
Sex differences in the effects of marijuana on simulated driving performance. Anderson BM, Rizzo M, Block RI, Pearlson GD, O'Leary DS. J Psychoactive Drugs. 2010 Mar;42(1):19-30.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033009/
Effects of THC on driving performance, physiological state and subjective feelings relative to alcohol. Ronen A, Gershon P, Drobiner H, Rabinovich A, Bar-Hamburger R, Mechoulam R, Cassuto Y, Shinar D. Accid Anal Prev. 2008 May;40(3):926-34. Epub 2007 Nov 26.
http://www.ncbi.nlm.nih.gov/pubmed/18460360
Muscle Spasms
Dystonia
http://www.norml.org/index.cfm?Group_ID=7006
“Marijuana and Muscle Spasticity” in Marijuana As Medicine? – The Science Behind the Controversy. Mack A and Joy J. National Academy of Science. National Academy Press, Washington DC 2000.
http://books.nap.edu/openbook.php?record_id=9586&page=106
Nausea
See sections 3.1 of Cannabinoids in medicine: A review of their therapeutic potential. Amar MB. Journal of Ethnopharmacology 105 (2006) 1–25.
http://www.ucla.edu.ve/dmedicin/departamentos/fisiologia/cannabinoidsRevPatologias.pdf
Pain
University of California Center for Medical Cannabis Research—2010 Report to the Legislature
http://www.cmcr.ucsd.edu/images/pdfs/CMCR_REPORT_FEB17.pdf
Chronic Pain
http://www.norml.org/index.cfm?Group_ID=7786
“Marijuana and Pain” in Marijuana As Medicine? – The Science Behind the Controversy. Mack A and Joy J. National Academy of Science. National Academy Press, Washington DC 2000.
http://books.nap.edu/openbook.php?record_id=9586&page=77#
Post traumatic Stress Disorder
Cannabinoid receptor activation in the basolateral amygdala blocks the effects of stress on the conditioning and extinction of inhibitory avoidance. Ganon-Elazar E, Akirav I. J Neurosci. 2009 Sep 9;29(36):11078-88.
http://www.jneurosci.org/content/29/36/11078.full.pdf+html
[Extinction of emotional response as a novel approach of pharmacotherapy of anxiety disorders]. Lehner M, Wisłowska-Stanek A, Płaznik A. Psychiatr Pol. 2009 Nov-Dec;43(6):639-53.
http://www.ncbi.nlm.nih.gov/pubmed/20209877
The Use of a Synthetic Cannabinoid in the Management of Treatment‐Resistant Nightmares in Posttraumatic Stress Disorder (PTSD). Fraser GA. CNS Neurosci Ther. 2009 Winter;15(1):84-8.
http://onlinelibrary.wiley.com/doi/10.1111/j.1755-5949.2008.00071.x/pdf
Public policy
Harm reduction-the cannabis paradox. Melamede R. Harm Reduct J. 2005 Sep 22;2:17.
http://www.harmreductionjournal.com/content/pdf/1477-7517-2-17.pdf
Seizures
See sections 3.7 of Cannabinoids in medicine: A review of their therapeutic potential. Amar MB. Journal of Ethnopharmacology 105 (2006) 1–25.
http://www.ucla.edu.ve/dmedicin/departamentos/fisiologia/cannabinoidsRevPatologias.pdf
“Marijuana and Neurological Disorders” in Marijuana As Medicine? – The Science Behind the Controversy. Mack A and Joy J. National Academy of Science. National Academy Press, Washington DC 2000.
http://books.nap.edu/openbook.php?record_id=9586&page=115

Last Tradhican · « **Reply #441 on:** March 29, 2022, 06:27:22 PM »

There goes Mark79 with yet another end run, switching to medical use again, which is not the issue or what this thread is about.

We are still waiting for articles from priests that say it is Ok to smoke MJ recreationally. I posted Fr. Scott and the SSPX saying it is a mortal sin, I could post many more articles from the Vatican II church.

But it is crickets on the question for now 30+ pages of insults, spam, chaff, and end runs from Mark79

Mark 79 · « **Reply #442 on:** March 29, 2022, 07:28:41 PM »

Read the title of the thread. This thread was NOT restricted to recreational use.

Further, the medical research informs us of the safety and benefits of marijuana, hence completely relevant to rational application of moral theology to the social use of marijuana.

Viva Cristo Rey · « **Reply #443 on:** March 29, 2022, 07:39:44 PM »

Quote from: Mark 79 on March 29, 2022, 05:54:29 PM

Have you stopped abusing your children?

Where did that come from??

Viva Cristo Rey · « **Reply #444 on:** March 29, 2022, 07:40:21 PM »

Quote from: Viva Cristo Rey on March 29, 2022, 05:28:13 PM

Most of you who smoke pot are probably in your 50s?

What is your diet? Junkfood or do you eat healthy? Just curious.

Why isn’t anyone answering these questions? How can we have a conversation??

trad123 · « **Reply #445 on:** March 29, 2022, 07:42:38 PM »

Quote from: Viva Cristo Rey on March 29, 2022, 07:39:44 PM

Where did that come from??

You asked a loaded question. He merely threw a loaded question back at you.

Mark 79 · « **Reply #446 on:** March 29, 2022, 07:42:57 PM »

Quote from: Viva Cristo Rey on March 29, 2022, 07:39:44 PM

Where did that come from??

Alzheimer's much? It was prompted by your moronic question:

Quote from: Viva Cristo Rey on March 29, 2022, 05:19:46 PM

Are you growing it yourself or are you buying from a drug dealer who sells to children or sex traffic young girls??

Have you stopped abusing your children?

Last Tradhican · « **Reply #447 on:** March 29, 2022, 07:48:49 PM »

Quote from: Mark 79 on March 29, 2022, 07:28:41 PM

Read the title of the thread. This thread was NOT restricted to recreational use.

Further, the medical research informs us of the safety and benefits of marijuana, hence completely relevant to rational application of moral theology to the social use of marijuana.

Mark79 is like a broken record or a parrot, just repeating the same lines. Here is how this thread started, I post it again:

Fighting Errors in the Modern World / Re: Marijuana use sinful for Catholics?
« on: March 21, 2022, 02:43:13 AM »
What started this thread:

Quote

Quote

Matthew wrote: You must be new here, son. Let me clue you in: roscoe totally owned it (smoking marijuana), admitted to it, and totally defended the smoking of pot by Catholics. There is no "alleged".

Not just new here, but lazy as well: a casual perusal of roscoe's past posts show a strong promotion/defense of Marijuana use....
I advertised this particular truth about "roscoe" because it was common knowledge on this forum 10 years ago. The posts are all still there. We even had a "smilie" for pot smoking. You might see some old posts that have text such as *smoke-pot* but it no longer renders into a graphic, because a lot of the old smilies have been removed. And yes, most people will take the philosophical and metaphysical musings of a habitual pot smoker with a grain of salt -- as they should. Do a CathInfo search for "mary juanita" by user "roscoe" and you'll see his long history.

and

Quote

Quote

Matthew wrote: I'm not particularly strong on the pot issue, either direction. I've heard all the "pros" and I certainly can't shoot any of them down.

My only point was: look at the public posting history of "roscoe", who rather controversially promotes this particular herb.

As the last several posts PROVE, it is still QUITE controversial in Catholic circles, to say the least.

We had a member on here a year ago post something against a priest. Turns out, the member in question was literally committed to a mental hospital. I think that's pretty relevant information when weighing "could it be true?" or "is that priest to be avoided or not"? Turns out, he later recanted and was relieved when I posted a followup to the thread. He asked for the thread to be taken down, but I couldn't, as the pillow full of feathers had already been burst asunder on a high windy hill, and now I needed to keep the thread up so people could quench ALL nagging doubts about said priest, because the allegations were unfounded, ravings of a mental patient, later retracted, etc.

But let's be honest -- if it came out that a prominent Traditional priest or bishop regularly "partook" of "the herb" there would be a ****storm on the interwebz, and you know it.

Viva Cristo Rey · « **Reply #448 on:** March 29, 2022, 07:49:57 PM »

Quote from: Viva Cristo Rey on March 29, 2022, 05:19:46 PM

Are you growing it yourself or are you buying from a drug dealer who sells to children or sex traffic young girls??

Do you buy from a dealer?( many do sell ti young people and yes many drug dealers sex traffic. ). Do you grow yourself?? Simple question.

Last Tradhican · « **Reply #449 on:** March 29, 2022, 07:51:07 PM »

And:

Fighting Errors in the Modern World / Re: Marijuana use sinful for Catholics?
« on: March 21, 2022, 03:03:20 AM »

What diverted this thread away from sins of the flesh associated with recreational use of Marijuana what Matthew was referring to with regard to Roscoe?

Answer: It was turned by Mark79 into a medical use of marijuana and its benefits thread.

Matthew was not talking about Roscoe's medical use.

Therefore, I return the subject of this thread to what it was originally, it is about recreational use of MJ. And because of the experience in other threads, I specifically request from Matthew that the subject be further restricted to use among young girls and boys and what we teach them and the example that we should set. THE reality today of what our children will be confronted.

Let's shine a light on the real issue, for it is not medical use or two old hippies with no children smoking "to relax" in their trailer in Arizona.